St. Denis J. Villere & Co’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,125
Closed -$3.02M 62
2022
Q1
$3.02M Sell
9,125
-1,265
-12% -$389K 0.18% 41
2021
Q4
$3.73M Sell
10,390
-25,736
-71% -$8.7M 0.21% 42
2021
Q3
$11.8M Sell
36,126
-170,945
-83% -$57.9M 0.68% 34
2021
Q2
$64.6M Sell
207,071
-41,609
-17% -$12.8M 3.46% 16
2021
Q1
$79.3M Sell
248,680
-1,520
-0.6% -$486K 4.34% 12
2020
Q4
$81.1M Buy
250,200
+24,220
+11% +$6.7M 4.9% 10
2020
Q3
$62.6M Sell
225,980
-2,150
-0.9% -$619K 4.21% 12
2020
Q2
$55.1M Buy
228,130
+77,180
+51% +$15.5M 3.95% 11
2020
Q1
$21.9M Sell
150,950
-2,240
-1% -$372K 1.87% 17
2019
Q4
$26.1M Sell
153,190
-153,323
-50% -$28.4M 1.71% 17
2019
Q3
$54.5M Buy
306,513
+71,792
+31% +$15.5M 3.66% 16
2019
Q2
$61.1M Buy
+234,721
New +$62.3M 3.75% 16

Other funds holding ABMD

St. Denis J. Villere & Co's ABMD Position: Q2 2022 in Review

St. Denis J. Villere & Co sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 9,125 shares — an estimated $3.02M sold.

St. Denis J. Villere & Co first reported a position in ABMD in Q2 2019 and held it in 12 quarters. The position peaked at $81.1M in Q4 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • St. Denis J. Villere & Co reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • St. Denis J. Villere & Co sold 9,125 Abiomed Inc shares in Q2 2022, an estimated $3.02M.
  • St. Denis J. Villere & Co first reported a position in Abiomed Inc in Q2 2019 and held it in 12 quarters.
  • St. Denis J. Villere & Co's Abiomed Inc position peaked at $81.1M in Q4 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on St. Denis J. Villere & Co's 13F filing for Q2 2022, filed 18 Jul 2022.